Couples undergoing in vitro fertilization
|
|
- Alice Gibbs
- 5 years ago
- Views:
Transcription
1 Current Methods for Preimplantation Genetic Diagnosis Zachary P. Demko, Ph.D., Matthew Rabinowitz, Ph.D., and David Johnson, Ph.D. Gene Security Network, Redwood City, CA Corresponding Author: David Johnson, Ph.D., Gene Security Network 2686 Middlefield Rd., Suite C. Redwood City, CA Introduction Couples undergoing in vitro fertilization (IVF) (1) have the unique opportunity to use pre-implantation genetic diagnosis (PGD) to select their best embryos for transfer, maximizing their chances of a successful pregnancy and the birth of a healthy child. In the 20 years since the first PGD babies were born (2), the technologies that have been available to fertility practitioners have advanced considerably. PGD was originally applied to couples with a family history of known genetic disease that wished to avoid conceiving an affected child. Such application of PGD typically screens for X-linked disorders such as Hemophilia A, monogenic diseases such as cystic fibrosis or specific chromosomal abnormalities such as reciprocal or Robertsonian translocations. Over time, the scope of PGD increased to include ploidy determination. Initially, only a small number of chromosomes were screened, typically 13, 18, 21, X and Y, allowing parents to avoid having a child afflicted with aneuploidy disorders such as Down Syndrome (Trisomy 21) or Edwards Syndrome (Trisomy 13). Currently, PGD is also used for couples that hope to improve the chances of a successful pregnancy based on the hypothesis that life-incompatible aneuploidies on other chromosomes are likely to result in embryo implantation failure or miscarriage. The following sections review the different technologies that have become available to fertility practitioners. Disease-Linked Genes The occurrence of genetic disease in both IVF and natural pregnancies can be devastating to families. Many genetic disorders are caused by rare single nucleotide mutations, whereas others are caused by insertions or deletions of stretches of nucleotides. Online Mendelian Inheritance in Man (OMIM), the largest public database of known genetic disorders, currently contains sequence information for more than 500 monogenic genetic diseases, and knowledge of genetic disease continues to grow. Parental carrier testing is currently available for over 1,000 heritable disease variants. This information, combined with genotypic knowledge of specific embryos, empowers parents to select those embryos with the greatest likelihood of developing into a healthy baby by deselecting embryos afflicted with genetic disease variants. Some of the most frequently diagnosed autosomal recessive disorders include cystic fibrosis, beta-thallasemia, and sickle cell disease. For dominant diseases myotonic dystrophy and Huntington s disease are among the most common. In the case of X-linked diseases, fragile X syndrome, haemophilia A and Duchenne muscular dystrophy account for most of the tests. All of these diseases have been successfully screened against in IVF embryos. Polymerase Chain Reaction (PCR) based methods Currently, most PGD labs test for single gene disorders using techniques based on the polymerase chain reaction (PCR), wherein the disease-linked locus is amplified from blastomere DNA using targeted 6
2 primers designed specifically for the mutation of interest (2-4). Typically, the blastomere DNA is amplified using PCR, and is then sequenced using dye end terminator sequencing or sized by electrophoresis (5). Some investigators have used multiplex PCR to measure multiple loci of interest in a single reaction (4,6). PCR methods are generally labor intensive and difficult to scale. One of the biggest drawbacks to the use of PCR-based techniques for gene detection in single cells is allele drop out (ADO), where the genetic variant of interest fails to amplify (5, 7-8). This may be caused by a number of factors, including cell loss upon handling, enucleated cells, failed lysis, and incomplete or differential amplification of one of the two alleles. ADO rates can vary widely given the conditions, anywhere from 10%, under ideal conditions, to more than 50% (5, 7-8). Increasing the number of cells analyzed significantly lowers the ADO rate, however, only 1-2 cells can be reasonably biopsied from an 8-10 cell Day 3 embryo. Trophectoderm biopsy, typically performed on Day 5 embryos, allows the biopsy of a larger quantity of cells. An additional benefit is that waiting for Day 5 to perform the biopsy allows for some self-correction of mosaic embryos that may have tested as aneuploid at day 3, but will ultimately develop properly (9-10). A drawback to Day 5 trophectoderm biopsy is that embryos typically need to be cryopreserved and then thawed, a technique that is costly and carries the risk of damage to the embryos. However, newer preservation and thawing techniques have been demonstrated to significantly reduce the harm to embryos (11). To address the problem of ADO, many PGD labs have begun using a method called preimplantation genetic haplotyping (PGH) (12-14). In PGH, known parental haplotypes at a set of alleles linked to the disease variant are amplified in parallel with the disease variant. If the disease variant allele drops out, then the linked alleles are used to determine whether the disease haplotype is present in the embryo. The method decreases the probability that ADO will cause a no result blastomere measurement. Aneuploidy PGD testing for numerical chromosome abnormalities (15-16) has four potential benefits: (a) to prevent the birth of a trisomic offspring by analyzing chromosomes X, Y, 13, 18 and 21, (b) to improve implantation rates, (c) to reduce pregnancy loss, and (d) to decrease multiple pregnancies by minimizing the number of embryos transferred per cycle. Current estimates suggest that at least 50% of human embryos are affected by aneuploidy and other chromosomal abnormalities (17-18). Data collected by comparative genomic hybridization and fluorescent in situ hybridization (FISH) suggest that as many as 70% of embryos from the most common age group of women (35 37 years old) undergoing IVF have chromosomal abnormalities, and as many as 82% for women 40 years old (19-21). The high prevalence of aneuploidy in human oocytes has been repeatedly documented (22-29) and is likely a major contributor. Oocyte karyotyping has shown that while women younger than 35 typically have rates of aneuploidy in oocytes of between 5% and 10%, by the time a woman is over 40 that rate has risen to above 50% (19, 26-29). Though current PGD methods significantly decrease the likelihood of a trisomic birth, it still remains the case that the majority of IVF cycles are unsuccessful, either due to a lack of embryo implantation or successful implantation followed by pregnancy loss. Regardless, we know that more than half of first trimester spontaneous miscarriages are chromosomally abnormal (30-32) and prenatal samples indicate a dramatic increase in aneuploidy rates in pregnancies with advancing maternal age (32), aneuploid fetuses that survive to term are often afflicted with developmental abnormalities such as Down s Syndrome and Edwards Syndrome. Thus, given that aneuploidy is a common and universally negative result, the ability to exclude aneuploid embryos from transfer is expected to increase the likelihood of delivering a healthy baby. The most common method of embryo selection, based on embryo morphology, ignores the underlying genetic state of the embryo. A number of groups have attempted to identify aneuploidy in a non-invasive way, such as detecting cell surface proteins or cellular excretions that are correlated with aneuploidy (33-34), however, the most reliable methods for aneuploidy detection require blastomere biopsy of an embryo. Traditional karyotyping is not widely practiced given the difficulty of obtaining metaphase blastomeres (35). The next section describes the most common and promising new techniques for ploidy determination. 7
3 Fluorescent in situ Hybridization Fluorescent in situ Hybridization (FISH) is a cytogenetic technique that uses a set of four molecular probes designed to anneal to specific regions of DNA on individual chromosomes (15-16). Each of the probes is labeled with a different dye, so that under a microscope the number of targeted chromosomes can be counted. FISH is able to detect aneuploidy in single blastomeres, and is currently the most common method for aneuploidy detection. A number of studies have shown that FISH screening for aneuploidy has resulted in a decrease in spontaneous miscarriage (36-37), and in other cases an increase in implantation rate, and live birth rate (36, 38-41). Other recent clinical studies have suggested that PGS with FISH does not improve implantation rates or live birth rates (42-47). However there is debate as to the validity of the methodology used in these studies (48-51). Despite its great promise, traditional FISH is limited in the number of chromosomes that can be tested: since there are only four dyes, only four chromosomes can be targeted at a time. To get around this limitation, multiple rounds of FISH on the same sample of DNA may be used, though the accuracy decreases with each round, and typically no more than eight chromosomes are screened. One study calculated that more than 20% of the embryos determined to be euploid using a typical eight chromosome FISH panel were likely aneuploid at untested chromosomes (18). This figure does not take into account the fact that the error rate with FISH for single cell screening is estimated to be between 3 and 15% (52-54). Comparative Genomic Hybridization Comparative Genomic Hybridization (CGH), a technique originally designed for evaluating chromosomal abnormalities in tumors (55), can be applied to embryos (17, 56-57). CGH involves amplifying DNA from both a blastomere and from a euploid control cell, under identical conditions, using fluorescently labeled nucleotides; green for the embryonic DNA, and red for the euploid control. The amplified, dye-labeled DNA is then hybridized to a slide spread with normal metaphase chromosomes. An excess of either red or green dye on a given chromosome, viewed manually under a microscope, indicates a chromosomal imbalance in the embryonic cell. Unlike FISH, CGH has no limitation as to the number of chromosomes that can be probed (17). However, accuracy rates of CGH have not yet been published. Additionally, a significant drawback to CGH is the length of time required for the procedure, typically four days, which precludes its use for PGD with fresh transfer, and necessitates embryo cryopreservation. Recent preliminary reports of shortened protocols indicate that this may not be a limitation in the future (58). Array CGH is a recent modification to this technology wherein the amplified, labeled DNA is hybridized to DNA probes affixed to a microarray (59-60). Because analysis is automated, array CGH allows for higher throughput evaluation of the dye ratios on the different chromosomes. Additionally, the time needed for the entire protocol can be as little as 12 hours, well within the short window between blastomere biopsy and transfer of the embryo. However, per-blastomere accuracy rates of array CGH for detecting aneuploidy might be as low as 71% (59). Methods That Test Concurrently for Both Aneuploidy and Single Gene Disorders. In the last few years, the use of single nucleotide polymorphism (SNP) microarrays for PGD has been introduced (18, 60-61). Typically, SNP microarrays can interrogate millions of individual SNPs located at numerous positions along each chromosome. The vast amount of information gleaned from SNP microarrays can be used for ploidy calling as well as genetic disease variant diagnosis. The microarray platforms typically involve oligonucleotide probes that are attached directly to the surface of solid supports, for example on slides or on beads, such that each probe has a specific, known location. In the Illumina system, the amplified and fluorescently labeled blastomere DNA is hybridized to the probes, which range from 25 to 85 nucleotides in length. Automated fluorescent readers then analyze the probes rapidly to determine hundreds of thousands to millions of genotypes in parallel (62). A major advantage of SNP microarrays is that a vast amount of quantitative data is generated. This necessitates modern bioinformatics-based techniques, which can be advantageous. For example, data are processed and analyzed automatically and in parallel. They also allow other information, such as confidences, to be calculated. Moreover, some informatics techniques 8
4 can be used to improve the accuracy of individual allele calls beyond the accuracy of the SNP microarray data itself (18, 63). This is especially important when the measurements are made on single cells, such as blastomeres, where the ADO rate is significant. SNP microarrays in single gene detection Single gene detection using SNP microarrays is relatively straightforward if the gene of interest corresponds to one of the probes on the microarray. One drawback to using SNP microarrays to detect single disease-linked SNPs is the significant potential for ADO upon amplification, and consequently a lack of diagnostic accuracy at the SNP of interest. However, a linkage approach, similar in concept to PGH, can overcome this drawback by using the identity of neighboring SNPs that correlate strongly with the mutation site to infer the correct identity of the target SNP (63, 65-66). When combined with parental information, SNP microarrays can be used to follow the inheritance of each parental chromosome, yielding data on the inheritance of genes associated with disease (63, 65-66). However, all methods that combine single gene diagnosis with aneuploidy screening await clinical validation studies before they become more commonplace at IVF clinics. One proprietary approach (18, 63) utilizes the microarray data from the embryonic DNA, the more accurate genetic data of the parents, and knowledge of the mechanism of meiosis to determine which segments of which parental chromosomes were inherited by the embryo. This allows the ploidy of the embryo to be determined with very high accuracy (18, 63). SNP microarrays in aneuploidy screening A number of strategies have leveraged the information available from SNP microarrays for ploidy determination. Average signal intensities of the probes corresponding to SNPs found on a given chromosome, or section of a chromosome, can be compared, and stronger or weaker responses are correlated with various types of aneuploidy (59-61, 64, 67). Another strategy is to enhance measurements on embryonic DNA by supplementing parental genetic data (18, 63, 65-66). Because all embryonic chromosomes are derived from parental chromosomes, parental data can be used to clean noisy single cell data. Whereas certain methods detect only some meiotic errors (65-66), a recently reported method detects both mitotic and meiotic errors (18). A major advantage to SNP microarrays is the potential for high accuracy of ploidy determinations. When SNP microarray data is processed using informatics-based techniques that incorporate parental information, error rates in ploidy determination can be up to an order of magnitude lower than with either FISH or CGH. In one study, where ploidy determinations were made using both embryonic and parental SNP 9
5 microarray data, reported average error rates were less than 1% per chromosome (18, 63). More importantly, this technique allows confidences to be calculated for each ploidy state determination so that clinical decisions can be made with maximal accuracy. In addition, some informatics-based methods are able to determine certain aneuploidy states that are otherwise not detectable using some other methods, such as uniparental disomy, maternal vs. paternal trisomy, and meiotic vs. mitotic trisomy (18, 63, 67). Given the high prevalence of mosaicism in embryos, and the ability for some mosaic embryos to self-correct (9-10, 68-73) the determination of the specific ploidy states can be helpful in predicting future outcomes. For example, it has been demonstrated that blastomeres with meiotic errors are less likely to belong to embryos with any euploid blastomeres, as compared to embryos with mitotic errors (18). Summary Over the last 20 years, the scope of PGD has expanded to include screening for a wide range of disease-linked genes, as well as screening for aneuploidy at all chromosomes. The vast amount of data available from SNP microarrays allows for simultaneous determination of most genetic conditions of interest using only the DNA from a single blastomere. When used in combination with informatics based data analysis, these determinations can be made rapidly, in parallel, and with accuracies significantly higher than possible with other techniques. The new PGD techniques will empower patients and clinicians to screen for almost any kind of genetic problem in embryos, with the potential to completely change the manner in which parents approach and manage genetic disease. n References 1) Centers for Disease Control and Prevention, American Society for Reproductive Medicine. (2008) Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2) Handyside AH, Lesko JG, Tarin JJ, Winston RM, Hughes MR. Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. New England Journal of Medicine. 1992;327: ) Liu J, Lissens W, Silber SJ, Devroey P, Liebaers I, Van Steirteghem A. Birth after preimplantation diagnosis of the cystic fibrosis delta F508 mutation by polymerase chain reaction in human embryos resulting from intracytoplasmic sperm injection with epididymal sperm. JAMA 1994;272: ) Sermon K, Lissens W, Nagy ZP, van Steirteghem A., Liebaers I. Simultaneous amplification of the two most frequent mutations of infantile Tay-Sachs disease in single blastomeres. Human Reproduction. 1995;10(8): ) Piyamongkol W, Bermâudez MG, Harper JC, Wells D. Detailed investigation of factors influencing amplification efficiency and allele drop-out in single cell PCR: implications for preimplantation genetic diagnosis. Molecular Human Reproduction. 2003;9(7): ) Findlay I, Urquhart A, Quirke P, Sullivan K, Rutherford AJ, Litford RJ. Simultaneous DNA fingerprinting, diagnosis of sex and single-gene defect status from single cells. Mol. Human Reproduction. 1995;1(2): ) Walsh PS, Erlich HA, Higuchi R. Preferential PCR amplification of alleles: Mechanisms and solutions. PCR Meth Appl. 1992;1, ) Findlay I, Ray P, Quirke P, Rutherford A, and Lilford R. Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation genetic diagnosis of sex and cystic fibrosis. Human Reproduction 1995;10(6): ) Baart EB, Van Opstal D, Los FJ, Fauser BCJM, Martini E. Fluorescence in situ hybridization analysis of two blastomeres from day 3 frozen-thawed embryos followed by analysis of the remaining embryo on day 5. Human Reproduction. 2004;19(3): ) Munné S, Velilla E, Colls P, Bermudez M, Vemuri M, Steuerwald N, Garrisi J, Cohen J. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fertility and Sterility. 2005;84: ) McArthur SJ, Leigh D, Marshall JT, de Boer KA, Jansen RP. Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts. Fertil Steril. 2005;84: ) Renwick PJ, Trusser J, Ostad-Saffari E, Fassihi H, Black C, Braude P, Ogilvie CM, Abbs S. Proof of principle and first cases using preimplantation genetic haplotyping a paradigm shift for embryo diagnosis. Reprod Biomed Online. 2006;13: ) Fiorentino F, Biricik A, Nuccitelli A, de Palma R, Kahraman S, Iacobelli M, Trengia V, Caserta D, Bonu MA, Borini A and Baldi M. Human Reproduction. 2006;21(3): ) Gutiérrez-Mateo C, Sánchez-García JF, Fischer J, Tormasi S, Cohen J, Munné S, Wells D. Preimplantation genetic diagnosis of single-gene disorders: experience with more than 200 cycles conducted by a reference laboratory in the United States. Fertility and Sterility. 2009;92(5): ) Delhanty JD, Griffin DK, Handyside AH, Harper J, Atkinson GH, Pieters MH, Winston RM. Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridisation, (FISH). Hum. Mol. Genet. 1993;2: ) Munné S, Lee A, Rosenwaks Z, Grifo J, Cohen J. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod. 1993;8: ) Wells D, Delhanty JD. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome 10
6 amplification and single cell comparative genomic hydbridization. Molecular Human Reproduction. 2000;6: ) Johnson DS, Gemelos G, Baner J, Ryan A, Cinnioglu C, Banjevic M, Ross R, Alper M, Barrett B, Frederick J, Potter D, Behr B, Rabinowitz M. Hum Reprod in press. 19) Gutierrez-Mateo C, Wells D, Benet J, Sánchez-García JF, Bermúdez MG. Reliability of comparative genomic hybridization to detect chromosome abnormalities in first polar bodies and metaphase II oocytes. Hum Reprod 2004; ) Munné S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates and maternal age are correlated with chromosome abnormalities. Fertility and Sterility. 1995;64: ) Márquez CSM, Bahçe M, Alikani M, Munné S. Chromosome abnormalities in 1255 cleavage-stage human embryos. Reprod Biomed Online. 2000;1(1); ) Pellestor F, André B, Arnal F, Humeau C, D le J. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet. 2003;112: ) Angell RR, Aitken RJ, van Look PF, Lumsden MA, Templeton AA. Chromosome abnormalities in human embryos after in vitro fertilization. Nature. 1983;303: ) Veiga A, Calderon G, Santalo J, Barri PN, Egozcue J. Chromosome studies in oocytes and zygotes from an IVF programme. Hum Reprod. 1987;2: ) Kamiguchi Y, Rosenbusch B, Sterzik K, Mikamo K. Chromosomal analysis of unfertilized human oocytes prepared by a gradual fixation-air drying method. Hum Genet. 1993; 90: ) Fragouli E, Wells D, Whalley KM, Mills JA, Faed MJW, Delhanty JDA. Increased susceptibility to maternal aneuploidy demonstrated by comparative genomic hybridization analysis of human MII oocytes and first polar bodies. Cytogenet. Genome. Res.2006;114(1): ) Fragouli E, Wells D, Thornhill A, Serhal P, Faed MJW, Harper JC, Delhanty JDA. Comparative genomic hybridization analysis of human oocytes and polar bodies. Hum Reprod. 2006;21(9): ) Sandalinas M, Marquez C, Munné S. Spectral karyotyping of fresh, non-inseminated oocytes. Mol Hum Reprod. 2002;8: ) Kuliev A, Cieslak J, Ilkevitch Y, Verlinsky Y. Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies. Reprod Biomed Online. 2003; 6: ) Hassold TJ, Jacobs PA. Trisomy in Man. Annu Rev Genet. 1984;18: ) Menasha J, Levy B, Hirschhorn K, Kardon NB. Incidence and spectrum of chromosome abnormalities in spontaneous abortions: new insights from a 12-year study. Genet Med 2005;7: ) Simpson JL. Causes of fetal wastage. Clinical Obstetrics and Gynecology. 2007;50(1): ) Katz-Jaffe MG, Gardner DK, Schoolcraft WB. Proteomic analysis of individual human embryos to identify novel biomarkers of development and viability. Fertility and Sterility 2006;85: ) Wells D, Fragouli E, Bianchi V, Obradors A, Delhanty J, Patrizio P. Comprehensive characterization of gene expression in human oocytes and identification of perturbations associated with meiotic aneuploidy, maturation and infertile pathology. Fertil Steril. 2006;86:S40 S41. 35) Shkumatov A, Kuznyetsov V, Cieslak J, Ilkevitch Y, Verlinsky Y. Obtaining metaphase spreads from single blastomeres for PGD of chromosomal rearrangements. Reprod. Biomed. Online 2007;14(4): ) Munné S, Chen S, Fisher J, Colls P, Zheng X, Stevens J, Escudero T, Oter M, Schoolcraft B, Simpson JL et al. Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertility and Sterility. 2005;84: ) Schoolcraft WB, Katz-Jaffe MG, Stevens J, Rawlins M, Munné S. Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertility and Sterility. 2008;92(1): ) Wells D, Fragouli E, Stevens J, Munne S, Schoolcraft W, Katz-Jaffe M. High pregnancy rate after comprehensive chromosomal screening of blastocysts. Fertil Steril. 2008;90:S80. 39) Munné S, Magli C, and Bahçe M. Fung J, Legator M, Morrison L, et al. Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22. Prenatal Diagnosis 1998;18: ) Munné S, Sandalinas M, Escudero T, Velilla E, Walmsley R, Sadowy S, et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online. 2003;7: ) Gianaroli L, Magli MC, Ferraretti AP, Munne S. Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with poor prognosis: identification of the categories to which it should be proposed. Fertility and Sterility 1999;72: ) Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod. 2004;19: ) Masternbroek S, Twisk M, van Echten-Arends J, Sikkema- Raddatz B, Korevaar JC, Verhoeve HR, Vogel NEA, Arts EGJM, de Vries JWA, Bossuyt PM, Buys CHCM, Heineman MJ, Repping S, van der Veen F. In Vitro Fertilization with Preimplantation Genetic Screening. N Engl J Med. 2007;357: ) Staessen C, Verpoest W, Donoso P, Haentjens P, van der Elst J, Liebaers I, Devroey P. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following singleembryo transfer. Hum Reprod. 2008;23(12): ) Hardarson T, Hanson C, Lundin K, Hillensjö T, Nilsson L, Stevic J, Reismer E, Borg K, Wikland M, Bergh C. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod 2008;23(12): ) Meyer LR, Klipstein S, Hazlett WD, Nasta T, Mangan P, Karande VC. A prospective randomized controlled trial of preimplantation genetic screening in the good prognosis patient. Fertility and Sterility. 2008;91(5): ) Debrock S, Melotte C, Spiessens C, Peeraer K, Vanneste E, 11
7 Meeuwis L, Meuleman C, Frijns JP, Vermeesch JR, D Hooghe TM. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertil Steril [Epub ahead of print]. 48) Munné S, Cohen J, Simpson JL. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007;357: ) Munné S, Gianaroli L, Tur-Kaspa I, Magli C, Sandalinas M, Grifo J, Cram D, Kahraman S, Verlinsky Y, Simpson JL. Substandard application of preimplantation genetic screening may interfere with its clinical success. Fertil Steril. 2007b;88: ) Simpson JL. What next for preimplantation genetic screening? Randomized clinical trial in assessing PGS: necessary but not sufficient. Human Reproduction 2008;23(10): ) Cohen J, Grifo JA. Multicentre trial of preimplantation genetic screening reported in the New England Journal of Medicine: an in-depth look at the findings. Reproductive BioMedicine Online 2008;15(4): ) Findlay I, Corby N, Rutherford A, and Quirke P. Comparison of FISH, PRINS, and conventional and fluorescent PCR for single-cell sexing: suitability for preimplantation genetic diagnosis. Journal of Assisted Reproduction and Genetics. 1998;15: ) Munné S, Chen SH, Colls P, Garrisi J, Zheng X, Cekleniak N, Lenzi M, Hughes P, Fischer J, Garrisi M, Tomkin G, Cohen J. Maternal age, morphology, development, and chromosome abnormalities in over 6000 cleavage-stage embryos. Reproductive BioMedicine Online. 2007;14(5): ) Daphnis DD, Fragouli E, Economou K, Jerkovic S, Craft IL, Delhanty JDA, Harper JC. Analysis of the evolution of chromosome abnormalities in human embryos from Day 3 to 5 using CGH and FISH. Molecular Human Reproduction 2008;14(2): ) Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258: ) Wells D, Delhanty J. Evaluating comparative genomic hybridisation (CGH) as a strategy for preimplantation diagnosis of unbalanced chromosome complements. Eur J Hum Genet. 1996;4(Suppl 1): ) Voullaire L, Slater H, Williamson R, Wilton L. Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Hum Genet 2000;106: ) Landwehr C, Montag M, van der Ven K, and Weber RG. Rapid comparative genomic hybridization protocol for prenatal diagnosis and its application to aneuploidy screening of human polar bodies. Fertility and Sterility 2008;90(3): ) Hu DG, Webb G, Hussey N. Aneuploidy detection in single cells using DNA array-based comparative genomic hybridization. Mol Hum Reprod. 2004;10: ) Wells D, Bermudez MG, Steuerwald N, Chu L, Weier U, Cohen J, Munne S. Microarrays for analysis and diagnosis of human embryos. In: Papp Z, Rodeck C (eds). Recent Advances in Prenatal Genetic Diagnosis. Medimond, 2004; ) Treff NR, Su J, Mavrianos J, Bergh PA, Miller KA, Scott RT. Accurate 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphism (SNP) microarrays. Fertility and Sterility. 2007;88:S1. 62) Gunderson KL, Steemers FJ, Ren H, Ng P, Zhou L, Tsan C, Chang WH, Bullis D, Musmacker J, King C, Lebruska LL, Barker D, Oliphant A, Kuhn KM, Shen R. Whole-Genome Genotyping. Methods in Enzymology. 2006;410: ) Rabinowitz M, Johnson DS, Salzman J, Banjevic M, Cinnioglu C, Behr B. Reliable concurrent calling of multiple genetic alleles and 24-chromosome ploidy without embryo freezing using Parental Support TM technology (PS). Fertil Steril 2008;90(Suppl 1):S23. 64) Kearns WG, Pen R, Benner A, Kittai A, Widra E, Leach R. SNP microarray genetic analyses to determine 23-chromosome ploidy, structural chromosome aberrations and genome-wide scans to identify disease risks from a single embryonic cell. Fertil Steril. 2008;90(Suppl 1):S23. 65) Handyside AH, Thornhill AR, Affara NA, Harton GL, Mariani BD, Griffin DK. Recombination mapping: a universal molecular karyotyping method for preimplantation genetic diagnosis of inherited disease. Fertil Steril. 2008;90(Suppl 1):S24. 66) Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara NA, Shaw MA, Griffin DK. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. Journal of Medical Genetics [Epub ahead of print] Oct ) Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, Debrock S, Amyere M, Vikkula M, Schuit F, Fryns JP, Verbeke G, D Hooghe T, Moreau Y, Vermeesch JR. Chromosome instability is common in human cleavage-stage embryos. Nat Med. 2009;15(5): ) Veiga A, Gil Y, Boada M, Carrera M, Vidal F, Bosio L. Confirmation of Diagnosis in Preimplantation Genetic Diagnosis (PGD) through blastocyst culture: preliminary experience. Prenat. Diagn.1999; 19: ) Ziebe S, Lundin K, Loft A, Bergh C, Nyboe Andersen A, Selleskog U, Nielsen D, Grøndahl C, Kimand H, Arce J-C. FISH analysis for chromosomes 13, 16, 18, 21, 22, X and Y in all blastomeres of IVF pre-embryos from 144 randomly selected donated human oocytes and impact on pre-embryo morphology. Hum. Reprod. 2003;18: ) Bielanska M, Jin S, Bernier M, Tan SL, Ao A. Diploidaneuploid mosaicism in human embryos cultured to the blastocyst stage. Fertility and Sterility 2005;84: ) Baart EB, Martini E, van den Berg I, Macklon NS, Galjaard R-JH, Fauser BCJM, Van Opstal D. Preimplantation genetic screening reveals a high incidence of 86 aneuploidy and mosaicism in embryos from young women undergoing IVF. Human Reproduction 2006;21(1): ) Baart EB, Martini E, Eijkemans MJ, van Opstal D, Beckers NGM, Verhoeff A, Macklon and NS, Fauser BCJM. Human Reproduction. 2007;22(4): ) Barbash-Hazan S, Frumkin T, Malcov M, Yaron Y, Cohen T, Azem F, Amit A, Ben-Yosef D. Preimplantation aneuploid embryos undergo self-correction in correlation with their developmental potential. Fertility and Sterility. 2009;92(3):
Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now?
Human Reproduction Vol.23, No.12 pp. 2617 2621, 2008 doi:10.1093/humrep/den400 EDITORIAL COMMENTARY Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now?
More informationSNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH
Molecular Human Reproduction, Vol.16, No.8 pp. 583 589, 2010 Advanced Access publication on May 19, 2010 doi:10.1093/molehr/gaq039 NEW RESEARCH HORIZON Review SNP microarray-based 24 chromosome aneuploidy
More informationPreimplantation Genetic Testing
Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical
More informationIndications for chromosome screening Dagan Wells, PhD, FRCPath dagan.wells@obs-gyn.ox.ac.ukgyn.ox.ac.uk Chromosome imbalance (aneuploidy) Uncontroversial data The incidence of aneuploidy Aneuploidy is
More informationProblem Challenge Need. Solution Innovation Invention
Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978
More informationAn Update on PGD: Where we are today
An Update on PGD: Where we are today Joyce Harper UCL Centre for PG&D and CRGH Institute for Womens Health University College London Overview What is PGD/PGS How we do it Disadvantages and advantages Future
More informationReview Preimplantation testing for chromosome aneuploidy
Review 2008;10:88 92 10.1576/toag.10.2.088.27396 www.rcog.org.uk/togonline The Obstetrician & Gynaecologist Review Preimplantation testing for chromosome aneuploidy Author Caroline Mackie Ogilvie Key content:
More informationClinical application of comprehensive chromosomal screening at the blastocyst stage
Clinical application of comprehensive chromosomal screening at the blastocyst stage William B. Schoolcraft, M.D., a Elpida Fragouli, Ph.D., b,c John Stevens, M.S., a Santiago Munne, Ph.D., d Mandy G. Katz-Jaffe,
More informationIncidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients
Incidence of Chromosomal Abnormalities from a Morphologically Normal Cohort of Embryos in Poor- Prognosis Patients M. C. MAGLI,1 L. GIANAROLI,1,3 S. MUNNE,2 and A. P. FERRARETTI1 Submitted: December 29,
More informationValidation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos
Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos Cristina Gutierrez-Mateo, Ph.D., a Pere Colls, Ph.D., a Jorge Sanchez-Garcıa, Ph.D., a Tomas
More informationPregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations
Pregnancy outcomes following 24-chromosome preimplantation genetic diagnosis in couples with balanced reciprocal or Robertsonian translocations Dennis Idowu, M.D., a Katrina Merrion, M.S., b Nina Wemmer,
More informationChromosomal Aneuploidy
The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common
More informationSNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts
J Assist Reprod Genet (2016) 33:1115 1119 DOI 10.1007/s10815-016-0734-0 TECHNOLOGICAL INNOVATIONS SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation
More informationThe relationship between blastocyst morphology, chromosomal abnormality, and embryo gender
IN VITRO FERTILIZATION The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender Samer Alfarawati, M.S. a,b Elpida Fragouli, Ph.D., a,b Pere Colls, Ph.D., c John Stevens,
More informationUSA: Livingston, NJ. PGD for infertility. Europe: Barcelona, Spain Oxford, UK Hamburg, Germany. Asia: Kobe, Japan. South America: Lima, Peru
PGD for infertility Santiago Munné USA: Livingston, NJ Europe: Barcelona, Spain Oxford, UK Hamburg, Germany Asia: Kobe, Japan South America: Lima, Peru The majority of embryos with good morphology are
More informationArticle Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes
RBMOnline - Vol 6. No 2. 226 231 Reproductive BioMedicine Online; www.rbmonline.com/article/794 on web 28 January 2003 Article Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes
More informationArticle Pre-embryonic diagnosis for Sandhoff disease
RBMOnline - Vol 12. No 3. 2006 328-333 Reproductive BioMedicine Online; www.rbmonline.com/article/2100 on web 9 January 2006 Article Pre-embryonic diagnosis for Sandhoff disease Dr Anver Kuliev received
More informationComprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?
Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Embryo 1 Embryo 2 combine samples for a single sequencing chip Barcode 1 CTAAGGTAAC
More informationEmbryoCellect TM. Pre-implantation Genetic Screening Kit TECHNICAL INFORMATION
EmbryoCellect TM Pre-implantation Genetic Screening Kit TECHNICAL INFORMATION Aneuploidy Whole chromosome aneuploidy has been shown to affect all chromosomes in IVF embryos. Aneuploidy is a significant
More informationTargeted qpcr. Debate on PGS Technology: Targeted vs. Whole genome approach. Discolsure Stake shareholder of GENETYX S.R.L
Antonio Capalbo, PhD Laboratory Director GENETYX, reproductive genetics laboratory, Italy PGT responsible GENERA centers for reproductive medicine, Italy Debate on PGS Technology: Targeted vs. Whole genome
More informationA Stepwise Approach to Embryo Selection and Implantation Success
Precise Genetic Carrier Screening An Overview A Stepwise Approach to Embryo Selection and Implantation Success Put today s most advanced genetic screening technology to work for you and your family s future.
More informationThe use of arrays in preimplantation genetic diagnosis and screening
MODERN TRENDS Edward E. Wallach, M.D. Associate Editor The use of arrays in preimplantation genetic diagnosis and screening Joyce C. Harper, Ph.D., a and Gary Harton, B.S. b a Reader in Human Genetics
More informationOriginal Policy Date
MP 2.04.77 Preimplantation Genetic Testing Medical Policy Section OB/Gyn/Reproduction Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to
More informationValidation of Next-Generation Sequencer for 24-Chromosome Aneuploidy Screening in Human Embryos
GENETIC TESTING AND MOLECULAR BIOMARKERS Volume 21, Number 11, 2017 ª Mary Ann Liebert, Inc. Pp. 1 7 DOI: 10.1089/gtmb.2017.0108 ORIGINAL ARTICLE Validation of Next-Generation Sequencer for 24-Chromosome
More informationBlastocentesis: innovation in embryo biopsy
Blastocentesis: innovation in embryo biopsy L. Gianaroli, MC Magli, A. Pomante, AP Ferraretti S.I.S.Me.R. Reproductive Medicine Unit, Bologna, Italy Bologna, 8-11 May 2016 www.iiarg.com www.sismer.it 2013
More informationPreimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More informationAccuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis
Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis Catherine M. DeUgarte, M.D., a Man Li, M.D., Ph.D., b Mark Surrey, M.D., c Hal Danzer,
More informationPreimplantation diagnosis: a realistic option for assisted reproduction and genetic practice Anver Kuliev and Yury Verlinsky
Preimplantation diagnosis: a realistic option for assisted reproduction and genetic practice Anver Kuliev and Yury Verlinsky Purpose of review Preimplantation genetic diagnosis (PGD) allows genetically
More informationPGS & PGD. Preimplantation Genetic Screening Preimplantation Genetic Diagnosis
1 PGS & PGD Preimplantation Genetic Screening Preimplantation Genetic Diagnosis OUR MISSION OUR MISSION CooperGenomics unites pioneering leaders in reproductive genetics, Reprogenetics, Recombine, and
More informationScientific and Clinical Advances Advisory Committee Paper
Scientific and Clinical Advances Advisory Committee Paper Paper title Paper number SCAAC(06/15)07 Meeting date 10 June 2015 Agenda item 7 Author Information/decision Resource implications Implementation
More informationRole of Preimplantation Genetic Diagnosis (PGD) in Current Infertility Practice
IJIFM REVIEW ARTICLE Role of Preimplantation Genetic Diagnosis (PGD) in Current Infertility Practice Role of Preimplantation Genetic Diagnosis (PGD) in Current Infertility Practice Helen Ghislaine Tempest,
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationArticle Preimplantation diagnosis and HLA typing for haemoglobin disorders
RBMOnline - Vol 11. No 3. 2005 362-370 Reproductive BioMedicine Online; www.rbmonline.com/article/1853 on web 20 July 2005 Article Preimplantation diagnosis and HLA typing for haemoglobin disorders Dr
More informationCongreso Nacional del Laboratorio Clínico 2016
Actualización en Screening Genético Preimplantacional Maria Giulia Minasi Center for Reproductive Medicine European Hospital Rome, Italy Aneuploidy rate can reach 60% in human embryos Aneuploidy increases
More informationESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD
Human Reproduction, Vol.00, No.0 pp. 1 8, 2010 doi:10.1093/humrep/deq230 ESHRE PAGES ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD G.L. Harton 1,,*, J.C.
More information1 PGS (PGS) IVF PGS, PGS,, PGS 2, PGS : (PGS); PGS; ; : R321.1 : A : X(2015) PGS 1995, 1 , (ART)
35 2 Vol.35 No.2 2015 2 Feb. 2015 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2015.02.0114 E-mail: randc_journal@163.com 1 123 (1. 200011) (2. 200011) (3. 200011) () IVF 2 : () : R321.1
More informationArray comparative genomic hybridization screening in IVF significantly reduces number of embryos available for cryopreservation
ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2012.39.2.52 pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2012;39(2):52-57 Array comparative genomic hybridization screening in IVF significantly
More informationAbstract. Introduction
RBMOnline - Vol 13 No 6. 2006 869-874 Reproductive BioMedicine Online; www.rbmonline.com/article/2507 on web 18 October 2006 Article Preimplantation genetic diagnosis significantly improves the pregnancy
More informationComprehensive molecular cytogenetic analysis of the human blastocyst stage
Human Reproduction Vol.23, No.11 pp. 2596 2608, 2008 Advance Access publication on July 29, 2008 doi:10.1093/humrep/den287 Comprehensive molecular cytogenetic analysis of the human blastocyst stage E.
More informationArticles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation embryos
RBMOnline - Vol 5. No 3. 306 312 Reproductive BioMedicine Online; www.rbmonline.com/article/699 on web 12 September Articles Impact of parental gonosomal mosaicism detected in peripheral blood on preimplantation
More informationArticle Successful pregnancies after application of array-comparative genomic hybridization in PGS-aneuploidy screening
RBMOnline - Vol 17 No 6. 2008 841-847 Reproductive BioMedicine Online; www.rbmonline.com/article/3419 on web 30 October 2008 Article Successful pregnancies after application of array-comparative genomic
More informationCurrent value of preimplantation genetic aneuploidy screening in IVF
Human Reproduction Update, Vol.13, No.1 pp. 15 25, 2007 Advance Access publication September 7, 2006 doi:10.1093/humupd/dml043 Current value of preimplantation genetic aneuploidy screening in IVF P.Donoso
More informationCIC Edizioni Internazionali. Preimplantation genetic screening: definition, role in IVF, evolution and future perspectives. Summary.
Mini-review Preimplantation genetic screening: definition, role in IVF, evolution and future perspectives Antonio Capalbo 1 Cristina Poggiana 2 Cristina Patassini 2 Anna Checchele 2 Emiliano Scepi 2 Danilo
More informationNew methods for embryo selection: NGS and MitoGrade
New methods for embryo selection: NGS and MitoGrade Santiago Munné, PhD US: Livingston, Los Angeles, Chicago, Portland, Miami / Europe: Barcelona (Spain), Oxford (UK), Hamburg (Germany) / Asia: Kobe (Japan),
More information@ CIC Edizioni Internazionali. Origin and mechanisms of aneuploidies in preimplantation embryos
Review article Preimplantation genetic screening: definition, role in IVF, evolution and future perspectives Antonio Capalbo 1 Cristina Poggiana 1 Cristina Patassini 1 Anna Cecchele 1 Emiliano Scepi 1
More informationEffect of chromosomal translocations on the development of preimplantation human embryos in vitro
FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A.,2 Effect of chromosomal
More informationTips and Tricks in Fluorescence In-situ Hybridization (FISH)- based Preimplantation Genetic Diagnosis /Screening (PGD/PGS)
International Journal of Medical Laboratory 2018;5(2):84-98. Review Article Tips and Tricks in Fluorescence In-situ Hybridization (FISH)- based Preimplantation Genetic Diagnosis /Screening (PGD/PGS) Fatemeh
More informationUvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication
UvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication Citation for published version (APA): Mastenbroek, S. (2011). Preimplantation
More informationORIGINAL ARTICLE Reproductive genetics
Human Reproduction, Vol.28, No.5 pp. 1426 1434, 2013 Advanced Access publication on March 10, 2013 doi:10.1093/humrep/det053 ORIGINAL ARTICLE Reproductive genetics Polar body analysis by array comparative
More informationArticles Diagnosis of trisomy 21 in preimplantation embryos by single-cell DNA fingerprinting
RBMOnline - Vol 4. No 1. 43 50 Reproductive BioMedicine Online; www.rbmonline.com/article/394 on web 6 December 2001 Articles Diagnosis of trisomy 21 in preimplantation embryos by single-cell DNA fingerprinting
More informationS.Kahraman 1,4, M.Bahçe 2,H.Şamlı 3, N.İmirzalıoğlu 2, K.Yakısn 1, G.Cengiz 1 and E.Dönmez 1
Human Reproduction vol.15 no.9 pp.2003 2007, 2000 Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation
More informationComprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study
ORIGINAL ARTICLES: ASSISTED REPRODUCTION Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study Richard T. Scott
More informationComparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement
Comparison of development and implantation of human embryos biopsied with two different methods: aspiration and displacement Wei-Hua Wang, Ph.D., Khalied Kaskar, M.S., Yuhong Ren, M.S., Jimmy Gill, M.D.,
More informationIdentification of embryonic chromosomal abnormality using FISH-based preimplantaion genetic diagnosis
Ye et al. / J Zhejiang Univ SCI 2004 5(10):1249-1254 1249 Journal of Zhejiang University SCIENCE ISSN 1009-3095 http://www.zju.edu.cn/jzus E-mail: jzus@zju.edu.cn Identification of embryonic chromosomal
More informationArticle Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening?
RBMOnline - Vol 12. No 3. 2006 334-339 Reproductive BioMedicine Online; www.rbmonline.com/article/1947 on web 25 January 2006 Article Which patients with recurrent implantation failure after IVF benefit
More informationEmbryo morphology and development are dependent on the chromosomal complement
Embryo morphology and development are dependent on the chromosomal complement M. Cristina Magli, M.Sc., Luca Gianaroli, M.D., Anna Pia Ferraretti, M.D., Ph.D., Michela Lappi, B.Sc., Alessandra Ruberti,
More informationASSISTED REPRODUCTION TECHNOLOGIES. Martin D. Keltz & Mario Vega & Ido Sirota & Matthew Lederman & Erin L. Moshier & Eric Gonzales & Daniel Stein
J Assist Reprod Genet (2013) 30:1333 1339 DOI 10.1007/s10815-013-0070-6 ASSISTED REPRODUCTION TECHNOLOGIES Preimplantation Genetic Screening (PGS) with Comparative Genomic Hybridization (CGH) following
More informationMALBAC Technology and Its Application in Non-invasive Chromosome Screening (NICS)
MALBAC Technology and Its Application in Non-invasive Chromosome Screening (NICS) The Power of One Adapted from Internet Single Cell Genomic Studies Ultra Low Sample Input Advances and applications of
More informationPreimplantation Diagnosis for Sonic Hedgehog Mutation Causing Familial Holoprosencephaly
The new england journal of medicine brief report Preimplantation Diagnosis for Sonic Hedgehog Mutation Causing Familial Holoprosencephaly Yury Verlinsky, Ph.D., Svetlana Rechitsky, Ph.D., Oleg Verlinsky,
More informationValidation of a next-generation sequencing based protocol for 24-chromosome aneuploidy screening of blastocysts
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 Q3 Q1 Q2 ORIGINAL ARTICLE: GENETICS
More informationMedical Policy Preimplantation Genetic Testing
Medical Policy Preimplantation Genetic Testing Document Number: 004 Commercial* and Connector/ Qualified Health Plans Authorization required X No notification or authorization Not covered * Not all commercial
More informationDiagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics
Diagnostic Techniques to Improve the Assessment of Human IVF Embryos: Genomics and Proteomics Mandy G Katz-Jaffe Introduction A fundamental component of assisted reproductive technologies (ART) is the
More informationPreimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC
Preimplantation Genetic Testing Where are we going? Genomics Clinical Medicine Symposium Sept 29,2012 Jason Flanagan, MS,CGC Overview Discuss what PGD and PGS are Pt examples What we have learned Where
More informationA BS TR AC T. n engl j med 357;1 july 5, 2007
The new england journal of medicine established in 1812 july 5, 2007 vol. 357 no. 1 In Vitro Fertilization with Preimplantation Genetic Screening Sebastiaan Mastenbroek, M.Sc., Moniek Twisk, M.D., Jannie
More informationDevelopment of new comprehensive
Development and validation of an accurate quantitative real-time polymerase chain reaction based assay for human blastocyst comprehensive chromosomal aneuploidy screening Nathan R. Treff, Ph.D., a,b Xin
More informationNEXCCS. Your guide to aneuploidy screening
NEXCCS Your guide to aneuploidy screening GROWING FAMILIES What is comprehensive chromosome screening? Comprehensive chromosome screening (CCS), also known as preimplantation genetic screening (PGS) or
More informationArticles Polar body-based preimplantation diagnosis for X-linked disorders
RBMOnline - Vol 4. No 1. 38 42 Reproductive BioMedicine Online; www.rbmonline.com/article/384 on web 20 November 2001 Articles Polar body-based preimplantation diagnosis for X-linked disorders Dr Yury
More informationUvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication
UvA-DARE (Digital Academic Repository) Preimplantation genetic screening: a reappraisal Mastenbroek, S. Link to publication Citation for published version (APA): Mastenbroek, S. (2011). Preimplantation
More informationIVF Michigan, Rochester Hills, Michigan, and Reproductive Genetics Institute, Chicago, Illinois
FERTILITY AND STERILITY VOL. 80, NO. 4, OCTOBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. CASE REPORTS Preimplantation
More informationTABLE 1. Both the family and the Ethical Commission of the hospital were informed about and consented to the application of the DF-DGP.
CASE REPORT Outcome of twin babies free of Von Hippel Lindau disease after a double-factor preimplantation genetic diagnosis: monogenetic mutation analysis and comprehensive aneuploidy screening Albert
More informationC H A P T E R Molecular Genetics Techniques for Preimplantation Genetic Diagnosis
Author, please provide citation of references 82, 83 in the text C H A P T E R Molecular Genetics 16 Techniques for Preimplantation Genetic Diagnosis Francesco Fiorentino, Gayle M Jones Introduction HISTORICAL
More informationDNA Microarray Reveals That High Proportions of Human Blastocysts from Women of Advanced Maternal Age Are Aneuploid and Mosaic 1
BIOLOGY OF REPRODUCTION (2012) 87(6):148, 1 9 Published online before print 7 November 2012. DOI 10.1095/biolreprod.112.103192 DNA Microarray Reveals That High Proportions of Human Blastocysts from Women
More informationLuca Gianaroli, M.D.,* M. Cristina Magli, M.Sc.,* Anna P. Ferraretti, Ph.D.,* and Santiago Munné, Ph.D.
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Preimplantation diagnosis
More informationPreimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses
RECURRENT PREGNANCY LOSS Preimplantation genetic diagnosis (PGD) improves pregnancy outcome for translocation carriers with a history of recurrent losses Jill Fischer, M.S., Pere Colls, Ph.D., Tomas Escudero,
More informationTechnical Update: Preimplantation Genetic Diagnosis and Screening
No. 323, May 2015 (Replaces No. 232, August 2009) Technical Update: Preimplantation Genetic Diagnosis and Screening This technical update has been prepared by the Genetics Committee and approved by the
More informationAbstract. Introduction. RBMOnline - Vol 10. No Reproductive BioMedicine Online; on web 19 January 2005
RBMOnline - Vol 10. No 3. 2005 381-388 Reproductive BioMedicine Online; www.rbmonline.com/article/1593 on web 19 January 2005 Article Preimplantation genetic diagnosis for aneuploidy screening in repeated
More informationAbstract. Introduction. RBMOnline - Vol 11. No Reproductive BioMedicine Online; on web 11 August 2005
RBMOnline - Vol 11. No 4. 2005 497 506 Reproductive BioMedicine Online; www.rbmonline.com/article/1712 on web 11 August 2005 Article FISH screening of aneuploidies in preimplantation embryos to improve
More informationRandomized comparison of next-generation sequencing and array comparative genomic hybridization for preimplantation genetic screening: a pilot study
Yang et al. BMC Medical Genomics (2015) 8:30 DOI 10.1186/s12920-015-0110-4 RESEARCH ARTICLE Open Access Randomized comparison of next-generation sequencing and array comparative genomic hybridization for
More informationThe role of the PGD Consortium. Overview. ESHRE PGD Consortium - Aims
The role of the PGD Consortium Joyce Harper Chair of the ESHRE PGD Consortium Overview Aims Membership Data Pregnancies Guidelines Training courses/education/post congress workshops Working groups PGS
More informationPre-implantation genetic diagnosis and pre-implantation genetic screening: two years experience at a single center
Original Article Obstet Gynecol Sci 2018;61(1):95-101 https://doi.org/10.5468/ogs.2018.61.1.95 pissn 2287-8572 eissn 2287-8580 Pre-implantation genetic diagnosis and pre-implantation genetic screening:
More informationAccurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays
Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays Nathan R. Treff, Ph.D., a,b Jing Su, M.Sc., a Xin Tao, M.Sc., a Brynn
More informationDetection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit
APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationZygotes showing a single pronucleus
In vitro development and chromosome constitution of embryos derived from monopronucleated zygotes after intracytoplasmic sperm injection Sílvia Mateo, M.Sc., a Monica Parriego, M.Sc., a Montserrat Boada,
More information24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015.
Learning objectives Family genetics: The future??? Peter Illingworth Medical Director IVFAustralia Understand how genetic problems may affect successful conception Consider the possible conditions and
More informationPolar Body Approach to PGD. Anver KULIEV. Reproductive Genetics Institute
Polar Body Approach to PGD Anver KULIEV Reproductive Genetics Institute DISCLOSURE othing to disclose 14 History of Polar Body Approach 14 First proposed in World Health Organization s Document Perspectives
More informationPreimplantation genetic diagnosis: current status and new developments
Human Reproduction vol.12 no.8 pp.1756 1761, 1997 Preimplantation genetic diagnosis: current status and new developments Willy Lissens 1 and Karen Sermon However, owing to the risk of misdiagnosis (one
More informationPreimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
More informationIncrease your chance of IVF Success. PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0)
Increase your chance of IVF Success PGT-A Preimplantation Genetic Testing for Aneuploidy (PGS 2.0) What is PGT-A? PGT-A, or Preimplantation Genetic Testing for Aneuploidy (PGS 2.0), is a type of genomic
More informationClinical applications of preimplantation genetic testing
Clinical applications of preimplantation genetic testing Paul R Brezina, 1 2 William H Kutteh 1 2 1 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Vanderbilt
More informationBlastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo
Original Article Blastocyst Morphology Holds Clues Concerning The Chromosomal Status of The Embryo Rita de Cassia Savio Figueira, M.Sc. 1, Amanda Souza Setti, B.Sc. 1,, Daniela Paes Almeida Ferreira Braga,
More informationKent Academic Repository
Kent Academic Repository Full text document (pdf) Citation for published version Gould, Rebecca L and Griffin, Darren K. (2017) Karyomapping and how is it improving preimplantation genetics? Expert Review
More informationNext generation technologies for PGD and 24- chromosome aneuploidy testing. PGD s 25 Year Journey: What is next?
Scientific Program 10 May 2015- Sunday 08:30 Pre-Congress Course Next generation technologies for PGD and 24- chromosome aneuploidy testing Sponsored by Illumina (invite only) 14:00 Illumina Focus Group
More informationFrom the earliest years of IVF, it
24-chromosome copy number analysis: a comparison of available technologies Alan H. Handyside, M.A., Ph.D. Bluegnome, Fulbourn, Cambridge; and Institute of Integrative and Comparative Biology, University
More informationINSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018
INSIDE IVF: HOW SCIENCE CARES FOR PATIENTS DR DEIRDRE ZANDER-FOX MONASH IVF GROUP HDA GRAND ROUND OCTOBER 31 ST 2018 IVF-THE ULTIMATE GOAL FERTILISATION EMBRYO CLEAVAGE AND DEVELOPMENT POSITIVE HCG POSITIVE
More informationArticle Differences in chromosome susceptibility to aneuploidy and survival to first trimester
RBMOnline - Vol 8. No 1. 81-90 Reproductive BioMedicine Online; www.rbmonline.com/article/1058 on web 4 November 2003 Article Differences in chromosome susceptibility to aneuploidy and survival to first
More informationUCLA UCLA Previously Published Works
UCLA UCLA Previously Published Works Title Recent advances in preimplantation genetic diagnosis and screening. Permalink https://escholarship.org/uc/item/6gc712qc Journal Journal of assisted reproduction
More informationArticle Negligible interchromosomal effect in embryos of Robertsonian translocation carriers
RBMOnline - Vol 10. No 3. 2005 363-369 Reproductive BioMedicine Online; www.rbmonline.com/article/1630 on web 17 January 2005 Article Negligible interchromosomal effect in embryos of Robertsonian translocation
More informationDetecting mosaicism in trophectoderm biopsies: current challenges and future possibilities
Human Reproduction, Vol.32, No.3 pp. 492 498, 2017 Advanced Access publication on October 13, 2016 doi:10.1093/humrep/dew250 OPINION Detecting mosaicism in trophectoderm biopsies: current challenges and
More informationAbstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 10 December 2003
RBMOnline - Vol 8. No 2. 224-228 Reproductive BioMedicine Online; www.rbmonline.com/article/1133 on web 10 December 2003 Article Preimplantation genetic diagnosis for early-onset torsion dystonia Dr Svetlana
More information